Artificial intelligence (AI) is at the forefront of many major discussions surrounding personal finance, with AI models like ...

Icotrokinra is a first-in-class investigational targeted oral peptide that selectively blocks the IL-23 receptor 1 Filing based on four Phase 3 studies that met all primary and co-primary endpoints.